India Compulsory Licensing: What USTR Hearing Transcripts Say
This article was originally published in PharmAsia News
Executive Summary
Private assurances or not, the prickly debate around the use of compulsory licenses in India appears to have an ongoing subtext going by the transcript of statements by the US-India Business Council (USIBC) before the United States Trade Representative (USTR) at the 2016 Special 301 review public hearing.